Capricor Therapeutics
CAPR
#7991
Rank
$0.29 B
Marketcap
$6.36
Share price
-4.36%
Change (1 day)
-57.23%
Change (1 year)

Market capitalization of Capricor Therapeutics (CAPR)

Market cap: $0.29 Billion USD

As of December 2025 Capricor Therapeutics has a market cap of $0.29 Billion USD. This makes Capricor Therapeutics the world's 7991th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Capricor Therapeutics from 2002 to 2025

End of year Market Cap

Year Marketcap Change
2025$0.29 B-54.58%
2024$0.64 B325.17%
2023$0.15 B54.55%
2022$97.43 M37.7%
2021$70.75 M0.89%
2020$70.13 M948.19%
2019$6.69 M-48.01%
2018$12.86 M-68.32%
2017$40.62 M-28.64%
2016$56.92 M13.93%
2015$49.96 M13.8%
2014$43.9 M15.58%
2013$37.98 M1711.3%
2012$2.09 M-90.31%
2011$21.64 M0.79%
2010$21.47 M-34.49%
2009$32.77 M59.66%
2008$20.52 M-84.51%
2007$0.13 B4288.98%
2006$3.02 M-38.46%
2005$4.9 M0%
2004$4.9 M27.45%
2003$3.85 M-63.57%
2002$10.57 M

End of Day market cap according to different sources

On Dec 10th, 2025 the market cap of Capricor Therapeutics was reported to be:

$1.48 Billion USD
by Nasdaq info icon info icon
$0.29 Billion USD
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Cytokinetics
CYTK
$7.37 B 2,436.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
$43.62 M-85.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$497.61 B 171,037.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
$15.51 B 5,236.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
$1.87 B 544.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
$10.04 M-96.54%๐Ÿ‡บ๐Ÿ‡ธ USA